Hikma Pharmaceuticals PLC (FRA:H5P)
Germany
· Delayed Price · Currency is EUR 18.30
+0.20 (1.10%)
At close: Dec 5, 2025
Hikma Pharmaceuticals Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,043 | 5,344 | 4,558 | 3,853 | 6,115 | 6,477 | Upgrade
|
| Market Cap Growth | -23.15% | 17.25% | 18.28% | -36.98% | -5.59% | 13.77% | Upgrade
|
| Enterprise Value | 5,159 | 6,330 | 5,493 | 4,942 | 6,631 | 6,928 | Upgrade
|
| Last Close Price | 18.30 | 23.03 | 19.14 | 15.89 | 23.72 | 24.66 | Upgrade
|
| PE Ratio | 12.80 | 15.41 | 26.52 | 21.91 | 16.52 | 18.38 | Upgrade
|
| PS Ratio | 1.48 | 1.77 | 1.75 | 1.64 | 2.72 | 3.38 | Upgrade
|
| PB Ratio | 1.86 | 2.38 | 2.28 | 1.92 | 2.82 | 3.69 | Upgrade
|
| P/TBV Ratio | 3.59 | 4.79 | 4.59 | 4.07 | 4.46 | 6.29 | Upgrade
|
| P/FCF Ratio | 13.08 | 13.87 | 11.48 | 10.51 | 14.11 | 27.13 | Upgrade
|
| P/OCF Ratio | 9.01 | 9.81 | 8.29 | 7.77 | 10.90 | 17.08 | Upgrade
|
| EV/Sales Ratio | 1.92 | 2.10 | 2.11 | 2.10 | 2.95 | 3.62 | Upgrade
|
| EV/EBITDA Ratio | 7.97 | 8.33 | 7.62 | 7.88 | 10.50 | 12.96 | Upgrade
|
| EV/EBIT Ratio | 10.64 | 10.78 | 9.71 | 10.61 | 13.44 | 15.70 | Upgrade
|
| EV/FCF Ratio | 16.69 | 16.42 | 13.83 | 13.47 | 15.30 | 29.03 | Upgrade
|
| Debt / Equity Ratio | 0.61 | 0.56 | 0.54 | 0.60 | 0.34 | 0.43 | Upgrade
|
| Debt / EBITDA Ratio | 2.01 | 1.64 | 1.46 | 1.88 | 1.16 | 1.40 | Upgrade
|
| Debt / FCF Ratio | 4.29 | 3.27 | 2.71 | 3.27 | 1.72 | 3.19 | Upgrade
|
| Asset Turnover | 0.62 | 0.64 | 0.63 | 0.57 | 0.60 | 0.58 | Upgrade
|
| Inventory Turnover | 1.82 | 1.82 | 1.76 | 1.70 | 1.73 | 1.70 | Upgrade
|
| Quick Ratio | 0.65 | 0.60 | 0.82 | 1.05 | 1.31 | 1.05 | Upgrade
|
| Current Ratio | 1.24 | 1.14 | 1.57 | 1.86 | 2.06 | 1.87 | Upgrade
|
| Return on Equity (ROE) | 15.38% | 15.98% | 8.81% | 8.28% | 18.20% | 20.11% | Upgrade
|
| Return on Assets (ROA) | 6.97% | 7.75% | 8.54% | 7.04% | 8.24% | 8.37% | Upgrade
|
| Return on Capital (ROIC) | 9.43% | 10.81% | 11.44% | 9.23% | 10.97% | 11.45% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.60% | 19.30% | 18.70% | 14.70% | 16.70% | 17.40% | Upgrade
|
| Earnings Yield | 7.81% | 6.49% | 3.77% | 4.57% | 6.05% | 5.44% | Upgrade
|
| FCF Yield | 7.65% | 7.21% | 8.71% | 9.52% | 7.09% | 3.69% | Upgrade
|
| Dividend Yield | 4.13% | 3.36% | 3.40% | 3.30% | 2.00% | 1.66% | Upgrade
|
| Payout Ratio | 47.71% | 48.75% | 72.10% | 66.49% | 28.50% | 25.29% | Upgrade
|
| Buyback Yield / Dilution | 0.18% | -0.51% | 1.13% | 3.47% | 2.10% | 2.06% | Upgrade
|
| Total Shareholder Return | 4.32% | 2.85% | 4.53% | 6.77% | 4.10% | 3.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.